Products from TargetMol
TargetMol, based in Boston, Massachusetts, was founded in 2015 and is a drug screening expert in the life science community. The company offers diverse compound libraries, including FDA-approved libraries, and covers a broad spectrum of small molecule compounds such as inhibitors and agonists as well as recombinant proteins and natural products. TargetMol's products are used by researchers worldwide in areas such as cancer research, neurobiology, inflammation, immunology and metabolism.
More information at: www.targetmol.com
No results were found for the filter!
UCL 2077
Item number: TGM-T17197-200mg
Description: UCL 2077 is a subtype-selective blocker of the epilepsy-associated KCNQ channels and it also is a selective slow-afterhyperpolarization channel blocker,with IC50 of 500 nM in hippocampal neurons in culture, having minimal effects on Ca2+ channels, action potentials, input resistance, and the medium...
| MW: | 350.46 D |
697.00€
*
Amfenac Sodium Hydrate
Item number: TGM-T1720-1g
Description: Amfenac Sodium Hydrate is a non-steroidal analgesic anti-inflammatory drug with acetic acid moiety. Target: Others, COX. Smiles: O.[Na+].Nc1c(cccc1CC(=O)[O-])C(=O)c1ccccc1
| Keywords: | Amfenac Sodium Monohydrate |
| MW: | 295.27 D |
113.00€
*
Amfenac
Item number: TGM-T1720L-100mg
Description: Amfenac promotes apoptosis in ARPE-19 cell culture. Target: Others. Smiles: O=C(O)CC=1C=CC=C(C(=O)C=2C=CC=CC2)C1N
| Keywords: | NSC309467 , NSC-309467 , NSC 309467 |
| MW: | 255.27 D |
2,371.00€
*
Vipivotide tetraxetan Linker
Item number: TGM-T17233-10mg
Description: Vipivotide tetraxetan Linker (PSMA-617 Linker) is a noncleavable peptide linker utilized in the synthesis of Vipivotide tetraxetan (PSMA-617), a ligand instrumental in producing 177Lu-PSMA-617. This radioactive molecule is applied in the treatment of prostate cancer[1]. Target: ADC Linker. Smiles:...
| Keywords: | PSMA-617 Linker |
| MW: | 655.74 D |
107.00€
*
VU0467154
Item number: TGM-T17244-200mg
Description: VU0467154 is a positive allosteric modulator of the M4 muscarinic acetylcholine receptor (M4 mAChR). Target: AChR. Smiles: NC=1C=2C(SC1C(NCC3=CC=C(S(C(F)(F)F)(=O)=O)C=C3)=O)=NN=C(C)C2C
| MW: | 444.45 D |
1,023.00€
*
WJ460
Item number: TGM-T17255-200mg
Description: WJ460 is an effective inhibitor of myoferlin. WJ460 exerts anti-metastatic activity in breast cancer cells. Target: Others. Smiles: COc1ccccc1N1C(SCC1=O)c1cccc(c1)C(=O)NCCCCc1ccccc1
| MW: | 460.59 D |
679.00€
*
WR99210
Item number: TGM-T17257-10mg
Description: WR99210 (BRL 6231 free base) is an orally available dihydrofolate reductase (DHFR) inhibitor with antiparasitic activity, often used in combination with dapsone to study Mycobacterium avium complex (MAC). Target: DHFR, Parasite. Smiles: ClC=1C=C(Cl)C(OCCCON2C(=NC(=NC2(C)C)N)N)=CC1Cl
| Keywords: | WR 99210 , BRL 6231 free base , WR-99210 |
| MW: | 394.68 D |
209.00€
*
WR99210
Item number: TGM-T17257-500mg
Description: WR99210 (BRL 6231 free base) is an orally available dihydrofolate reductase (DHFR) inhibitor with antiparasitic activity, often used in combination with dapsone to study Mycobacterium avium complex (MAC). Target: DHFR, Parasite. Smiles: ClC=1C=C(Cl)C(OCCCON2C(=NC(=NC2(C)C)N)N)=CC1Cl
| Keywords: | WR 99210 , BRL 6231 free base , WR-99210 |
| MW: | 394.68 D |
1,877.00€
*
WR99210
Item number: TGM-T17257-5mg
Description: WR99210 (BRL 6231 free base) is an orally available dihydrofolate reductase (DHFR) inhibitor with antiparasitic activity, often used in combination with dapsone to study Mycobacterium avium complex (MAC). Target: DHFR, Parasite. Smiles: ClC=1C=C(Cl)C(OCCCON2C(=NC(=NC2(C)C)N)N)=CC1Cl
| Keywords: | WR 99210 , BRL 6231 free base , WR-99210 |
| MW: | 394.68 D |
133.00€
*
WRG-28
Item number: TGM-T17258-200mg
Description: WRG-28 is a potent and selective, allosteric discoidin domain receptor 2 (ddr2) inhibitor(IC50 : 230 nM). Target: Discoidin Domain Receptor (DDR). Smiles: CCNS(=O)(=O)c1ccc(COc2ccc3nc4ccc(=O)cc4oc3c2)cc1
| MW: | 410.44 D |
907.00€
*
WWL70
Item number: TGM-T17260-2mg
Description: WWL70 is a selective inhibitor of alpha/beta hydrolase domain 6 with an IC50 of 70 nM. Target: Lipase, MAGL. Smiles: CN(Cc1cccc(c1)-c1ccncc1)C(=O)Oc1ccc(cc1)-c1ccc(cc1)C(N)=O
| MW: | 437.49 D |
33.00€
*
YUKA1
Item number: TGM-T17278-1mg
Description: YUKA1, a cell-permeable KDM5A inhibitor (IC50=2.66 µM) with a weak effect on KDM5C (IC50=7.12 µM) and no effect on other KDM isoforms, was able to increase the level of H3K4me3 in human cells and inhibit the proliferation of cancer cells, and also prevented the emergence of drug-resistant cells. Target:...
| Keywords: | YUKA 1 |
| MW: | 292.36 D |
106.00€
*